Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Invacare offers to buy Healthdyne

This article was originally published in Clinica

Executive Summary

Invacare wants to take over Healthdyne Technologies and is offering $12.50 a share in cash, valuing Healthdyne at some $158 million. The price offered by Invacare represents a premium of 40% over the share price on December 31st, 1996. Healthdyne says it will not consider the offer until its board meeting in February. The share price before the offer was made public was $9.25 and reached $13.25 by the close of January 13th.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT083503

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel